loader2
Partner With Us NRI

Company details

150.25
157.00
141.20
276.40
6M Return -4.42%
1Y Return -2.59%
Mkt Cap.(Cr) 234.12
Volume 538
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 538

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 127.12 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -37,122.02
LAST 3M 77,375.96 -51,746.13
LAST 6M 142,231.38 -195,441.57
LAST 12M 206,053.08 -175,138.09

Information

  • About Company
  • Company Info
  • Listing Info
48.76
68.25%
83.3004
3.51%
2.41%
Description
  • Incorporated in May `92 as a public limited company, Kilitch Drugs (India) (KDIL) went public in Feb.`94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct.`95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical. A Pharmaceutical formulation plant at Sana`a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation.It also entered into an agreement with a Miami company for the export of their medicine to West Indies, south and central America. The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5-cr tanning unit, which was implemented in the year 1995-96. The company had set up a bulk drug unit at Patalganga, Maharashtra for producing raw materials for formulations. The company exports to Sudan, Yemen, middle-east, Miami and certain south American companies. KDIL started marketing a range of injectables from the factory on ethical basis. The company also introduced a new product clue-plus, Bon-Bon Gripe Water and Kilitch Balm.

Read More

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524500
NSE Code : KILITCH
Book Closure Date (Month) :
BSE Group : B
ISIN : INE729D01010

ICICIdirect Kilitch Drugs (India) Ltd FAQ

You can buy Kilitch Drugs (India) Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Kilitch Drugs (India) Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 23, 2022 04:01 PM the closing price of Kilitch Drugs (India) Ltd was ₹ 150.25.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 23, 2022 04:01 PM, the market cap of Kilitch Drugs (India) Ltd stood at ₹ 234.12.
The latest PE ratio of Kilitch Drugs (India) Ltd as of May 23, 2022 04:01 PM is 48.76
The latest PB ratio of Kilitch Drugs (India) Ltd as of May 23, 2022 04:01 PM is 0.53
The 52-week high of Kilitch Drugs (India) Ltd is ₹ 276.40 while the 52-week low is ₹ 141.20 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE